Literature DB >> 2508711

HIV-1 and HIV-2 infection associated with AIDS in Abidjan, Côte d'Ivoire.

K Odehouri1, K M De Cock, J W Krebs, J Moreau, M Rayfield, J B McCormick, G Schochetman, R Bretton, G Bretton, D Ouattara.   

Abstract

In September 1987, a seroprevalence study of HIV-1 and HIV-2 infection was conducted among 956 people from different groups in Abidjan, Côte d'Ivoire. Groups examined were hospitalized patients (Internal Medicine and Infectious Disease Departments, Centre Hospitalier Universitaire de Treichville, Abidjan), outpatients at tuberculosis treatment centers, blood donors, women attending an antenatal clinic, and patients attending sexually transmitted disease (STD) clinics. Total HIV infection prevalence ranged from 10% in STD clinic patients and pregnant women to 45% in hospitalized patients on an infectious diseases service. Within groups, HIV-1 infection was 2-6.5 times more prevalent than infection with HIV-2. One-quarter of HIV-seropositive people were serologically reactive to both HIV-1 and HIV-2 on enzyme-linked immunosorbent assay and Western blot. Clinical conditions previously observed in patients with HIV-1 infection were observed in people infected with HIV-2 only, as well as in those with HIV-1 infection and dual serologic reactivity. An isolate of HIV-2 was obtained on culture from a person with wasting disease and chronic fever. The results of this study suggest that infection with HIV-1 and HIV-2 is epidemic in Côte d'Ivoire, and that HIV-2 may be associated with AIDS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508711     DOI: 10.1097/00002030-198908000-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  Changing Dynamics of HIV Transmission in Côte d'Ivoire: Modeling Who Acquired and Transmitted Infections and Estimating the Impact of Past HIV Interventions (1976-2015).

Authors:  Mathieu Maheu-Giroux; Juan F Vesga; Souleymane Diabaté; Michel Alary; Stefan Baral; Daouda Diouf; Kouamé Abo; Marie-Claude Boily
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

2.  Risk of tuberculosis in patients with HIV-I and HIV-II infections in Abidjan, Ivory Coast.

Authors:  K M De Cock; E Gnaore; G Adjorlolo; M M Braun; M F Lafontaine; G Yesso; G Bretton; I M Coulibaly; G M Gershy-Damet; R Bretton
Journal:  BMJ       Date:  1991-03-02

3.  Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.

Authors:  Modou Jobarteh; Marine Malfroy; Ingrid Peterson; Adam Jeng; Ramu Sarge-Njie; Abraham Alabi; Kevin Peterson; Matt Cotten; Andrew Hall; Sarah Rowland-Jones; Hilton Whittle; Richard Tedder; Assan Jaye; Maimuna Mendy
Journal:  Virol J       Date:  2010-09-15       Impact factor: 4.099

4.  A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

Authors:  Geoffrey S Gottlieb; Serge-Paul Eholié; John N Nkengasong; Sabelle Jallow; Sarah Rowland-Jones; Hilton C Whittle; Papa Salif Sow
Journal:  AIDS       Date:  2008-10-18       Impact factor: 4.177

5.  Natural killer cell function is well preserved in asymptomatic human immunodeficiency virus type 2 (HIV-2) infection but similar to that of HIV-1 infection when CD4 T-cell counts fall.

Authors:  Samuel Victor Nuvor; Marianne van der Sande; Sarah Rowland-Jones; Hilton Whittle; Assan Jaye
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.